HOCHAUFLÖSENDE ALLELIDENTIFIKATION

Patent europeic · EP3058095 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3058095
Numer da la dumonda
EP14843178
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
14-10-2014
Publitgà
24-08-2016
Concedì
25-12-2019
La protecziun finescha il pli tard
13-10-2034
Proxima taxa annuala scadenta
31-10-2026
Classas IPC
C12Q 1/6881 (2018.01)
G16B 20/00 (2019.01)
G16B 30/00 (2019.01)
Prioritad
US 201361891193 P 15.10.2013
Dumonda PCT
PCT/IB2014/002843 14.10.2014
Publicaziun PCT
WO2015/056103 23.04.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-11-2025

    Midada

    Published in Swissreg on 01.11.2025

  2. 01-11-2024

    Midada

    Published in Swissreg on 01.11.2024

  3. 01-11-2023

    Midada

    Published in Swissreg on 01.11.2023

  4. 01-11-2022

    Midada

    Published in Swissreg on 01.11.2022

  5. 24-03-2020

    Represchentant inscrit

    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano

    Published in Swissreg on 24.03.2020

  6. 25-12-2019

    Concedì

    Published in Swissreg on 25.12.2019

Partidas

Possessur

Regeneron Pharmaceuticals, Inc.

777 Old Saw Mill River Road Building 6, Room 63-136, Tarrytown, NY 10591-6706, US

Represchentant

Ing. Marco Zardi c/o M. ZARDI & Co. S.A.

via Pioda 6, 6900 Lugano

Inventur

BAI, Yu

Tarrytowon, NY 10591, US

FURY, Wen

Tarrytown, NY 10591, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.